Ian posted:

>Experiments involving risky drugs proceed with little independent oversight.
>Impoverished, poorly educated patients are sometimes tested without
>understanding that they are guinea pigs. And pledges of quality medical care
>sometimes prove fatally hollow, The Post found.
>
>Drugmakers hop borders with scant government review.
<snip>
>The companies use the tests to produce new products and new revenue streams,
>but they are also responding to pressure from regulators, Congress and
>lobbyists for disease victims to develop new medicines quickly. By providing
>huge pools of human subjects, foreign trials help speed new drugs to the
>marketplace where they will be sold mainly to patients in wealthy
>countries.

Besides capitalism & imperialism, the above problem has patient 
activism in rich nations as one of its causes, and the Washington 
Post is right to point it out, as unpalatable as this fact may be & 
patient-activists have been at most a minor player in drug 
development.  In the course of AIDS-related activism, for instance, 
patient-activists may have unwittingly helped to further drug 
companies' efforts to circumvent the regulations to bring drugs to 
the market as quickly as possible.  It's an instance of Gramscian 
hegemony at work.

Capitalism has, especially in recent years, increasingly 
proletarianized medical practitioners.  While proletarianization has 
produced a promising trend of unionization of medical doctors, at the 
same time, proletarianized doctors & other medical workers have lost 
relative autonomy of "professionals," thus lowering the quality of 
medicine.

Yoshie

Reply via email to